Skip to main content

Lung Cancer Research Foundation Archives

Potential target for lung cancer therapy

Oct. 5, 2015—The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more